Neumora Therapeutics, Inc. (NMRA)
3.39
-0.09
(-2.59%)
USD |
NASDAQ |
Feb 20, 16:00
3.385
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Total Assets (Quarterly) : 177.83M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ventyx Biosciences, Inc. | 211.46M |
| Protalix Biotherapeutics, Inc. | 82.26M |
| Puma Biotechnology, Inc. | 202.86M |
| Nautilus Biotechnology, Inc. | 200.92M |
| ProKidney Corp. | 351.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.67M |
| Shareholders Equity (Quarterly) | 132.16M |
| Debt to Equity Ratio | 0.152 |
| Current Ratio | 6.852 |
| Net Debt Paydown Yield | -1.12% |